OICR-0547 is primarily utilized in biochemical research as a potent and selective inhibitor of the protein kinase PIM1. This kinase plays a significant role in cell survival, proliferation, and differentiation, making OICR-0547 a valuable tool in studying cancer biology and related pathways. Researchers employ it to investigate the effects of PIM1 inhibition on tumor growth and progression, particularly in hematologic malignancies and solid tumors. Its application extends to exploring potential therapeutic strategies, as blocking PIM1 activity may disrupt cancer cell signaling and induce apoptosis. Additionally, OICR-0547 is used in combination studies with other inhibitors or chemotherapeutic agents to assess synergistic effects and enhance anti-cancer efficacy. Its specificity and potency make it a critical compound for advancing understanding of PIM1's role in disease and drug development.